[Respiratory syncytial virus]

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Respiratory syncytial virus (RSV) is a major global cause of respiratory infections.
• Severe illness, including bronchiolitis and pneumonia, affects preterm infants, infants, and the elderly, leading to high mortality rates.
• Current preventive and therapeutic options for RSV are limited.

Purpose of the Study:

• To highlight the significant global impact of RSV infections.
• To underscore the vulnerability of specific populations to severe RSV disease.
• To emphasize the unmet need for effective RSV interventions.

Main Methods:

• Literature review on RSV epidemiology and clinical impact.
• Analysis of current diagnostic capabilities for RSV.
• Overview of existing and emerging therapeutic strategies.

Main Results:

• RSV infection poses a substantial worldwide health burden.
• High-risk groups experience severe outcomes, necessitating intensive care.
• Rapid RSV detection contrasts with limited treatment and prevention.

Conclusions:

• There is a critical need for enhanced preventive strategies and novel therapeutics for RSV.
• Ongoing clinical trials for new antivirals offer potential future solutions.
• Addressing the RSV burden requires continued research and development.